RCM
MACK

Radnor Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Radnor Capital Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,332
Closed -$84K – 252
2022
Q1 		$84K Hold
13,332
– – 0.02% 240
2021
Q4 		$52K Buy
+13,332
New +$52K 0.01% 245